DK0395418T3 - Phospholipase A2-inhibitor, fremgangsmåde til fremstilling deraf og farmaceutiske eller veterinære formuleringer omfattende inhibitoren - Google Patents

Phospholipase A2-inhibitor, fremgangsmåde til fremstilling deraf og farmaceutiske eller veterinære formuleringer omfattende inhibitoren

Info

Publication number
DK0395418T3
DK0395418T3 DK90304552.4T DK90304552T DK0395418T3 DK 0395418 T3 DK0395418 T3 DK 0395418T3 DK 90304552 T DK90304552 T DK 90304552T DK 0395418 T3 DK0395418 T3 DK 0395418T3
Authority
DK
Denmark
Prior art keywords
inhibitor
compound
phospholipase
pharmaceutical
preparation
Prior art date
Application number
DK90304552.4T
Other languages
English (en)
Inventor
Tadasi Yoshida
Hitoshi Arita
Junichi Shoji
Keizo Inoue
Shigeru Matsutani
Yoshimi Kawamura
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0395418T3 publication Critical patent/DK0395418T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK90304552.4T 1989-04-28 1990-04-26 Phospholipase A2-inhibitor, fremgangsmåde til fremstilling deraf og farmaceutiske eller veterinære formuleringer omfattende inhibitoren DK0395418T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1109939A JP2842613B2 (ja) 1989-04-28 1989-04-28 フォスフォリパーゼa▲下2▼阻害物質

Publications (1)

Publication Number Publication Date
DK0395418T3 true DK0395418T3 (da) 1995-08-07

Family

ID=14522941

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90304552.4T DK0395418T3 (da) 1989-04-28 1990-04-26 Phospholipase A2-inhibitor, fremgangsmåde til fremstilling deraf og farmaceutiske eller veterinære formuleringer omfattende inhibitoren

Country Status (7)

Country Link
US (1) US5011952A (da)
EP (1) EP0395418B1 (da)
JP (1) JP2842613B2 (da)
AT (1) ATE123028T1 (da)
DE (1) DE69019591T2 (da)
DK (1) DK0395418T3 (da)
ES (1) ES2075154T3 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE141909T1 (de) * 1991-07-03 1996-09-15 Shionogi & Co Phospholipase a2 inhibitor
CA2100640A1 (en) * 1992-07-23 1994-01-24 Shigeru Matsutani Substitute benzoate derivatives
GB9226724D0 (en) * 1992-12-22 1993-02-17 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
US5011952A (en) 1991-04-30
DE69019591T2 (de) 1996-01-25
EP0395418B1 (en) 1995-05-24
JP2842613B2 (ja) 1999-01-06
DE69019591D1 (de) 1995-06-29
JPH02286088A (ja) 1990-11-26
ATE123028T1 (de) 1995-06-15
ES2075154T3 (es) 1995-10-01
EP0395418A1 (en) 1990-10-31

Similar Documents

Publication Publication Date Title
AU643489B2 (en) Antibacterial agents - II
DK0405864T3 (da) Phospholipase A2-inhibitor, mikroorganismer der producerer inhibitoren og fremgangsmåder til den fremstilling
FI813182L (fi) Foerfarande foer framstaellning av n-substituerade 1-desoxinojirimycinderivat
HUT56379A (en) Process for producing a-norsteroid-3-carboxylic acid derivatives and compositions comprising such compounds
FI901530A0 (fi) Menetelmä immunomoduloivien atsaspiraanien valmistamiseksi
AU4938985A (en) Polypeptide
DK546489A (da) Thienopyridin-mevalonolactoner, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat omfattende samme
DK0395418T3 (da) Phospholipase A2-inhibitor, fremgangsmåde til fremstilling deraf og farmaceutiske eller veterinære formuleringer omfattende inhibitoren
DK0641200T3 (da) 2-Arylpropionsyrepræparater og fremgangsmåde til fremstilling deraf
AU557494B2 (en) 2-substituted-5-arylimidazoles
PT98700A (pt) Processo para a preparacao de acidos aminometanofosfonico e de acidos aminometil-fosfinicos
HUT37116A (en) Process for production of phenil-alanin derivatives
ES8200922A1 (es) Procedimiento para preparar kijanimicina
EP0490224A3 (de) Salicylaldehyd- und Salicylsäurederivate sowie deren Schwefelanaloge, Verfahren und Zwischenprodukte zu ihrer Herstellung
FI902590A0 (fi) Foerfarande foer framstaellning av 2-oxoindol-1-karboxamider.
ATE41155T1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
AU1099888A (en) Novel imidazo- and triazolothiadiazines, a process for the preparation thereof, medicaments containing same, and the use thereof, and some intermediates formed in the preparation of the compounds mentioned
DE3882654T2 (de) Enzymhemmer und Methode zu dessen Herstellung.
ES8506689A1 (es) Procedimiento para la obtencion de esteres de acido cumalico
KR910006227A (ko) 크로토노베타인히드로클로리드의 제조방법
ATE236178T1 (de) Kristalline l-ascorbinsäure-2-phosphorsäure kaliumsalz und verfahren zu ihrer herstellung
ES8604491A1 (es) Procedimiento para la obtencion de derivados de diaril-eti- lamino
ATE132865T1 (de) 3-anilino-2-hydroxycarbonyl-4-thiophenessigsäur n
ES8200091A1 (es) Procedimiento para la produccion de n-((2s)-3-mercapto-2-me-tilpropionil)-l-prolina
JPS6450845A (en) Novel compound and production thereof